New research led by Dmitry Temiakov, Ph.D., of UMDNJ-School of Osteopathic Medicine, has identified important mechanisms of this genetic transfer process for the first time. These new findings, published in the journal Nature, open the door to developing potential therapies for several serious diseases including cancers. They also add to basic knowledge of the functioning of the healthy human body.
Each human cell harbors small organelles called mitochondria, which are responsible for the energy production of the cell, and therefore are often called the cell’s "power plant." Mitochondria contain their own genome which is maternally inherited and encodes numerous genes of proteins that are involved in energy production. Mitochondria are also believed to fuel harmful processes that can lead to the development of conditions that include diabetes, cancer and Parkinson’s disease, as well as the onset of cognitive impairment and other conditions associated with aging.
Because of this, therapy that targets the actions of mitochondria may be a promising strategy for mitigating and even reversing these illnesses, making understanding of molecular mechanisms of mitochondrial gene expression an important goal for researchers.
The current research sought to uncover structural information about mitochondrial (human) RNA polymerase, the key enzyme in the process of transferring genetic information from mitochondrial DNA to RNA, the molecule that carries that information to structures within cells that govern those cells’ function in the body. Mitochondrial RNA polymerase does not directly share its sequence or structural homology (common evolutionary origin) with large multi-subunit cellular RNA polymerases, the variety that appears in organisms such as bacteria and also in the nuclei of human cells. The lack of commonality between two distinct varieties of polymerase that coexist within human cells has intrigued the scientific community. Thus, the structure of multi-subunit RNA polymerase II has been a subject of intensive studies, including by Nobel Laureate Roger Kornberg. In 1984 David Clayton and colleagues demonstrated that mitochondrial RNA polymerase is related to a polymerase found in a small virus of E.coli bacterium, called phage T7. This was a surprising finding since it is believed that mitochondria originated from an endosymbiotic relationship (where one organism hosts the other) formed between bacteria and eukaryotes (cells that are the building blocks of organisms that include humans) and thus that the majority of mitochondrial proteins have bacterial homologies. Until now, specific structures and pathways involved could not be identified.
The team led by Temiakov sought to make such an identification by teaming up with the lab of one of the world's leading crystallographers, Prof. Patrick Cramer in Gene Center, Munich, Germany (http://www.lmb.uni-muenchen.de/cramer/patrickCramer/index.htm). The project was initiated about four years ago but only last year the team was able to obtain large, well-diffracting crystals of an active form of human mitochondrial polymerase. The structure was solved in Cramer's lab and reveals the mechanistic adaptations that occurred during evolution of a self-sufficient T7-like RNA polymerase to become regulated by transcription initiation factors. It is the first-ever representation of mitochondrial polymerase.
Temiakov says he and his colleagues were thrilled to make their discovery. “I would compare our own excitement about this structure with what anthropologists experience when they find an ancient hominid and can see changes in the skull and other bones that occurred during an evolution and resulted in modern human beings.”
The structural information can be used to understand how mitochondrial polymerase binds DNA, interacts with other mitochondrial proteins and regulates expression of mitochondrial genes under different conditions. This knowledge will guide many future biochemical and genetic experiments and will help to validate mitochondrial polymerase as a therapeutic target.
Journalists who wish to interview Dmitry Temiakov, Ph.D., are invited to contact Rob Forman, UMDNJ Chief of News Services, at 973-972-7276 or email@example.com .
The University of Medicine and Dentistry of New Jersey (UMDNJ) is the nation's largest free-standing public health sciences university with more than 6,000 students on five campuses attending the state's three medical schools, its only dental school, a graduate school of biomedical sciences, a school of health related professions, a school of nursing and New Jersey’s only school of public health. UMDNJ operates University Hospital, a Level I Trauma Center in Newark, and University Behavioral HealthCare, which provides a continuum of healthcare services with multiple locations throughout the state.
Rob Forman | Newswise Science News
Predicting a protein's behavior from its appearance
10.12.2019 | Ecole Polytechnique Fédérale de Lausanne
Could dark carbon be hiding the true scale of ocean 'dead zones'?
10.12.2019 | University of Plymouth
Graphene, a two-dimensional structure made of carbon, is a material with excellent mechanical, electronic and optical properties. However, it did not seem suitable for magnetic applications. Together with international partners, Empa researchers have now succeeded in synthesizing a unique nanographene predicted in the 1970s, which conclusively demonstrates that carbon in very specific forms has magnetic properties that could permit future spintronic applications. The results have just been published in the renowned journal Nature Nanotechnology.
Depending on the shape and orientation of their edges, graphene nanostructures (also known as nanographenes) can have very different properties – for example,...
Using a clever technique that causes unruly crystals of iron selenide to snap into alignment, Rice University physicists have drawn a detailed map that reveals...
University of Texas and MIT researchers create virtual UAVs that can predict vehicle health, enable autonomous decision-making
In the not too distant future, we can expect to see our skies filled with unmanned aerial vehicles (UAVs) delivering packages, maybe even people, from location...
With ultracold chemistry, researchers get a first look at exactly what happens during a chemical reaction
The coldest chemical reaction in the known universe took place in what appears to be a chaotic mess of lasers. The appearance deceives: Deep within that...
Abnormal scarring is a serious threat resulting in non-healing chronic wounds or fibrosis. Scars form when fibroblasts, a type of cell of connective tissue, reach wounded skin and deposit plugs of extracellular matrix. Until today, the question about the exact anatomical origin of these fibroblasts has not been answered. In order to find potential ways of influencing the scarring process, the team of Dr. Yuval Rinkevich, Group Leader for Regenerative Biology at the Institute of Lung Biology and Disease at Helmholtz Zentrum München, aimed to finally find an answer. As it was already known that all scars derive from a fibroblast lineage expressing the Engrailed-1 gene - a lineage not only present in skin, but also in fascia - the researchers intentionally tried to understand whether or not fascia might be the origin of fibroblasts.
Fibroblasts kit - ready to heal wounds
03.12.2019 | Event News
15.11.2019 | Event News
15.11.2019 | Event News
10.12.2019 | Architecture and Construction
10.12.2019 | Information Technology
10.12.2019 | Life Sciences